Mangoceuticals announces that it has secured a strategic partnership with the International Society of Frontier Life Sciences and Technology, ISFLST, for the distribution of its products in China and the Asia Pacific region and Latin America. This agreement marks a significant milestone in MangoRx’s expansion strategy, aiming to bring its premier men’s health solutions to the rapidly growing markets in these regions. Under this agreement, ISFLST, who has offices in the US, China and South Korea, will leverage its extensive network and expertise to introduce and promote MangoRx’s cutting-edge products across Asia and Latin America. The collaboration is designed to enhance brand visibility, drive product adoption, and meet the increasing demand for high-quality men’s health products in these areas.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGRX:
- Mangoceuticals receives Notice of Acceptance for patent application in Australia
- MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology
- Mangoceuticals Incentivizes Team with Equity Rewards
- Mangoceuticals gets Japan okay for preventive care tech acquired from Intramont
- MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies